These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8603437
1. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function. Cui H, Sherr DH, el-Khatib M, Matsui K, Panka DJ, Marshak-Rothstein A, Ju ST. Cell Immunol; 1996 Feb 01; 167(2):276-84. PubMed ID: 8603437 [Abstract] [Full Text] [Related]
2. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation. Cui H, el-Khatib M, Sherr DH, Ettinger R, Sy MS, Marshak-Rothstein A, Ju ST. Cell Immunol; 1996 Feb 01; 167(2):302-12. PubMed ID: 8603440 [Abstract] [Full Text] [Related]
3. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, Okumura K, Miyatake S, Saito T. Eur J Immunol; 1997 Aug 01; 27(8):1858-64. PubMed ID: 9295019 [Abstract] [Full Text] [Related]
4. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. Ettinger R, Panka DJ, Wang JK, Stanger BZ, Ju ST, Marshak-Rothstein A. J Immunol; 1995 May 01; 154(9):4302-8. PubMed ID: 7536768 [Abstract] [Full Text] [Related]
5. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O. Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501 [Abstract] [Full Text] [Related]
6. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Kaser A, Nagata S, Tilg H. Cytokine; 1999 Oct 10; 11(10):736-43. PubMed ID: 10525311 [Abstract] [Full Text] [Related]
7. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. Williams MS, Henkart PA. J Immunol; 1996 Sep 15; 157(6):2395-402. PubMed ID: 8805638 [Abstract] [Full Text] [Related]
8. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM. J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113 [Abstract] [Full Text] [Related]
9. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death. Nakano K, Saito K, Mine S, Matsushita S, Tanaka Y. Apoptosis; 2007 Jan 01; 12(1):45-54. PubMed ID: 17136494 [Abstract] [Full Text] [Related]
10. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells. Tóth R, Szegezdi E, Reichert U, Bernardon JM, Michel S, Ancian P, Kis-Tóth K, Macsári Z, Fésüs L, Szondy Z. Eur J Immunol; 2001 May 01; 31(5):1382-91. PubMed ID: 11465095 [Abstract] [Full Text] [Related]
11. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS. J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345 [Abstract] [Full Text] [Related]
12. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. Tucek-Szabo CL, Andjelić S, Lacy E, Elkon KB, Nikolić-Zugić J. J Immunol; 1996 Jan 01; 156(1):192-200. PubMed ID: 8598462 [Abstract] [Full Text] [Related]
13. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis. Rogers AM, Thilenius AR, Russell JH. J Immunol; 1997 Oct 01; 159(7):3140-7. PubMed ID: 9317111 [Abstract] [Full Text] [Related]
14. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function. Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, Dörken B. Eur J Immunol; 1997 Apr 01; 27(4):1029-34. PubMed ID: 9130660 [Abstract] [Full Text] [Related]
15. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. Moreno MB, Memon SA, Zacharchuk CM. J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614 [Abstract] [Full Text] [Related]
16. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Nature; 1995 Feb 02; 373(6513):444-8. PubMed ID: 7530337 [Abstract] [Full Text] [Related]
18. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression. Wang R, Brunner T, Zhang L, Shi Y. Oncogene; 1998 Sep 24; 17(12):1503-8. PubMed ID: 9794227 [Abstract] [Full Text] [Related]
19. Factors influencing the expression of Fas and Fas ligand on newborn murine keratinocytes and fibroblasts. He W, Zhao Y, Song F, Saitoh A, Shimada S. Chin Med J (Engl); 2000 Sep 24; 113(9):833-5. PubMed ID: 11776081 [Abstract] [Full Text] [Related]